| Literature DB >> 32724784 |
Su-Jin Kim1, Eun-Sun Yoon2, Sun-Young Jung3, Dae-Young Kim1,4.
Abstract
Metabolic disorders occurring in menopause, including dyslipidemia, disorders of carbohydrate metabolism, components of metabolic syndrome, constitute risk factors for cardiovascular disease in women. Irisin and fibroblast growth factor-21 (FGF-21), which regulate browning, and high molecular weight (HMW) adiponectin have emerged beneficial for metabolic health. The purpose of the study was to examine the effect of endurance aerobic exercise on circulating browning factor and HMW-adiponectin level in postmenopausal women. Twenty-five postmenopausal women were included in this study. The aerobic exercise program consisted of 60 min of walking exercise at 50%-60% maximum oxygen uptake, and conducted 3 times per week for 6 weeks. Body composition, blood pressure, lipid profiles, physical fitness, and concentration of plasma irisin, FGF-21, HMW-adiponectin were analyzed before and after exercise. Waist circumference, systolic blood pressure, and triglyceride levels decreased, and levels of high-density lipoprotein cholesterol, irisin increased after exercise. However, there were no significant changes in FGF-21 and HMW-adiponectin. Balance and flexibility among physical fitness indices improved after exercise. These results suggested that moderate intensity walking could be the ideal type of exercise in menopausal women to induce a positive change in metabolic health markers, including an increase in irisin levels. Further studies are needed to determine the effects of exercise on brown adipose tissue browning factor.Entities:
Keywords: Exercise; Fibroblast growth factor-21; High molecular weight adiponectin; Irisin; Postmenopausal women
Year: 2020 PMID: 32724784 PMCID: PMC7365724 DOI: 10.12965/jer.2040334.167
Source DB: PubMed Journal: J Exerc Rehabil ISSN: 2288-176X
Physical characteristics of the subjects (n=25)
| Characteristic | Mean±SD |
|---|---|
| Age (yr) | 60.28±5.30 |
| Height (cm) | 158.17±5.36 |
| Weight (kg) | 59.34±7.80 |
| Body fat (%) | 33.62±4.93 |
| Body mass index (kg/m2) | 23.72±2.91 |
SD, standard deviation.
Changes in the obesity indexes after 6 weeks of exercise training
| Variable | Pre | Post | ||
|---|---|---|---|---|
| Weight (kg) | 59.34±7.80 | 59.65±7.55 | 0.31±0.80 | 0.064 |
| BMI (kg/m2) | 23.72±2.91 | 23.85±2.81 | 0.12±0.32 | 0.062 |
| Body fat (%) | 33.62±4.93 | 33.31±5.30 | −0.31±1.73 | 0.377 |
| LBM (kg) | 21.15±2.57 | 21.39±2.69 | 0.24±0.58 | 0.053 |
| WC (cm) | 83.32±7.32 | 82.30±8.18 | −1.01±2.32 | 0.039 |
Values are presented as mean±standard deviation.
Δ score represents the difference in score after 6 weeks from the score before the exercise program.
BMI, body mass index; LBM, lean body mass; WC, waist circumference.
Changes in the metabolic risk factors after 6 weeks of exercise training
| Variable | Pre | Post | ||
|---|---|---|---|---|
| SBP (mmHg) | 127.76±14.60 | 120.64±10.96 | −7.12±14.25 | 0.020 |
| DBP (mmHg) | 76.44±17.72 | 73.12± 9.88 | −3.32±17.61 | 0.355 |
| Glucose (mg/dL) | 92.36±11.88 | 93.84±11.59 | 1.48±9.55 | 0.446 |
| HbA1c (%) | 5.41±0.66 | 5.31±0.73 | −0.10±0.34 | 0.158 |
| TC (mg/dL) | 187.92±34.92 | 172.72±29.86 | −15.20±16.53 | 0.001 |
| TG (mg/dL) | 112.44±84.74 | 72.08±30.89 | −40.36±78.70 | 0.017 |
| LDLC (mg/dL) | 106.19±31.04 | 92.63±28.27 | −10.96±20.63 | 0.001 |
| HDLC (mg/dL) | 60.56±13.02 | 64.40±11.64 | 3.84±7.40 | 0.016 |
Values are presented as mean±standard deviation.
Δ score represents the difference in score after 6 weeks from the score before the exercise program.
SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglycerides; LDLC, low-density lipoprotein cholesterol; HDLC, high-density lipoprotein cholesterol.
Changes in browning factor, adiponectin, HMW-adiponectin
| Variable | Pre | Post | ||
|---|---|---|---|---|
| Irisin (μg/mL) | 2.70±1.13 | 3.08±1.11 | 0.37±0.64 | 0.007 |
| FGF-21 (pg/mL) | 216.87±119.15 | 186.08±105.70 | −30.79±110.52 | 0.176 |
| Adiponectin (mg/dL) | 10.02±5.05 | 9.58±4.33 | −0.44±2.12 | 0.395 |
| HMW-adiponectin (ng/mL) | 3,511.67±2,226.37 | 3,288.30±2,183.52 | −623.36±1,174.62 | 0.309 |
Values are presented as mean±standard deviation.
Δ score represents the difference in score after 6 weeks from the score before the exercise program.
HMW, high molecular weight; FGF-21, fibroblast growth factor-21.
Changes in health-related physical fitness
| Variable | Pre | Post | ||
|---|---|---|---|---|
| Muscle strength (kg) | 37.91±14.86 | 36.12±12.77 | −1.78±5.65 | 0.259 |
| Muscle endurance (reps) | 16.16±10.85 | 19.56±11.89 | 3.40±8.74 | 0.064 |
| Flexibility (cm) | 17.09±7.24 | 19.59±5.90 | 2.50±3.73 | 0.003 |
| Balance (sec) | 10.05±6.99 | 21.63±21.03 | 11.58±21.13 | 0.011 |
Values are presented as mean±standard deviation.
Δ score represents the difference in score after 6 weeks from the score before the exercise program.